SP1 and liver dysplastic nodule: In this study, we delineated the metabolic pathway responsible for the SP1-guided transcription of dynein and tested whether disrupting this early transcription mechanism can halt the pathogenesis of diabetic podocytopathy and prevent the development of overt DN.